Lake Tahoe-based Medical Funding Professionals (MFP) has announced the addition of funding and capital generation expert Ron Flavin to its team as Co-Chair and Senior Strategist.
LAKE TAHOE, NV, December 14, 2020 – Lake Tahoe-based Medical Funding Professionals (MFP) has announced the addition of Ron Flavin to its team as Co-Chair and Senior Strategist.
“Ron brings a wealth of experience and contacts with him, thanks to his two decades of experience in the medical funding field,” said MFP CEO Stephen Brock.
Founded earlier this year, MFP is focused on helping growing businesses in the BioTech, MedTech, Life Sciences and Pharma sectors to secure growth capital through a variety of structures. As for Flavin, the move gives him the opportunity to focus more on medical startups, in keeping with the demands of the COVID-19 pandemic.
According to industry journal MedCity News: “As the scale of the pandemic grows and downstream impacts persist, healthcare organizations are recognizing they must shift from a reactive stance to a more proactive ‘new normal.’ Operating in this environment will require new capabilities, forcing many organizations to look externally for innovative solutions to guide this transformation.”
For MFP, the process begins with a practice it calls the Capital Planning Valuation Strategy™, or CPVS™.
The CPVS offers an in-depth analysis of the company’s valuation, potential, and appropriate funding strategies. This may include the Reg A+ funding route, or another alternative, such as: grants, convertible debentures, SAFE notes, or other funding strategies. According to the firm, the greatest feature of the Reg A+ funding through the CPVS process is that it leaves more of the company in the founders’ hands vs. other equity funding methods, in which investors tend to demand a large equity share, aka “shark deals”.
According to securities attorney Brenda Hamilton, “Regulation A (Reg A+) offers an alternative to the traditional methods of filing a Registration Statement on Form S-1 or Form F-1 to raise capital and go public, while preserving some of the key benefits of those traditional registered offerings.”
Implemented by the SEC in 2015, Regulation A+ allows an exemption from the registration requirements of the Securities Act of 1933 for companies that meet certain qualifications and are making an offering of up to $75 million in a one-year period. Reg A+ offerings are intended to make access to capital possible for small and medium-sized companies that could not otherwise bear the costs of a normal SEC registration and to allow non‑accredited investors to participate in the offering.
The MFP approach to Reg A+ funding might prove a comfortable fit for many medically related short-term and long-term startups and mid-market private & public companies, such as those introducing vaccines or other drugs, whose cash flow might not begin until their product is tested. Reg A+ funding offers a faster and easier way to raise up to $75 million per year—all while maintaining higher valuation and without giving up the governance and economic control that is more common when raising funds through venture capital, angel investors, private equity and others. Unlike broker-dealers, MFP does not raise capital for companies. Instead, it analyzes each company individually and designs the most beneficial strategy to enable the company to locate the capital it needs.
“We tailor our solutions to fit the individual needs of companies seeking capital for their operations and growth,” explained CEO and founder Stephen Brock.
“Stephen and I have worked together in the past,” Flavin said, “and I have always admired his professional ethic and overall commitment. What excites me most about working with MFP is that it will allow me to not only help founders in the BioTech, MedTech, Life Sciences and Pharma sectors to quickly and easily secure the growth capital they need through Reg A+ funding, but it will also enable me to help them secure government grants and other government-backed non-traditional funding instruments to help them raise non-dilutive capital as well.”
About Ron Flavin
A lifelong entrepreneur, Ron Flavin is passionate about helping startups develop and implement growth and funding strategies that enable them to achieve their most ambitious goals. He has launched successful startups around the globe and over the last ten years, he has helped his clients to secure well over $400 million in funding, enabling them to launch, grow, reach new markets, increase market share, extend their brand, expand internationally and much more.
Ron also knows what drives funding decisions and has led or been part of decision-making teams that have awarded more than $1 billion in funding over the last five years. He has a keen understanding of the global business landscape and has worked around the globe including Germany, Spain, Switzerland, the United Kingdom, South America and Asia. As a subject matter expert, he has appeared in the New York Times, on CNN International and other local and national media outlets. He is committed to supporting startup entrepreneurs around the globe, volunteering his time mentoring others through the Cleantech Open, Pacific Community Ventures, the Duke Startup Challenge and Bridge to Billions. Most recently, he served as Co-Director of the San Francisco Founder Institute, led by global entrepreneur Adeo Ressi. In this capacity, Ron has worked alongside some of the most notable names in entrepreneurship and finance, including Jason Calacanis, Phil Libin and many others.
About Medical Funding Professionals
Medical Funding Professionals provides funding solutions to short-term and long-term startups and mid-market private & public companies in BioTech, MedTech, Life Sciences & Pharma industries. MFP tailors solutions to fit the individual needs of companies seeking capital for their operations and growth.
Disclaimer: None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any product or financial instrument, to make any investment, or to participate in any particular investment, offering, or trading strategy. The information and materials provided here, whether or not provided on Medical Funding Professionals emails, website/webpages, on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and educational purposes. We are not a broker-dealer. The information is not investment advice. Investment involves risk. Past performance is not indicative of future performance. If you have any questions, you should seek independent professional advice.
Medical Funding Professionals
Ron Flavin Inc.